Individualized Duration of Antibiotic Treatment in Early Onset Infection in Newborns.

Clinical trial NCT05329701 · COMPLETED

Trial details

NCT number: NCT05329701
Sponsor: Ulrikka Nygaard
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Early-Onset Neonatal Sepsis Antibiotic Side Effect

Start date: 2022-04-22
Primary completion: 2025-04-05
Enrollment: 488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.